KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $71.5 billion.

  • Bristol Myers Squibb's Total Liabilities fell 614.31% to $71.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $71.5 billion, marking a year-over-year decrease of 614.31%. This contributed to the annual value of $71.5 billion for FY2025, which is 614.31% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Total Liabilities of $71.5 billion as of Q4 2025, which was down 614.31% from $78.3 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Total Liabilities high stood at $82.5 billion for Q1 2024, and its period low was $61.5 billion during Q2 2023.
  • In the last 5 years, Bristol Myers Squibb's Total Liabilities had a median value of $73.5 billion in 2021 and averaged $71.6 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Total Liabilities crashed by 1259.86% in 2023, and later skyrocketed by 3219.49% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Total Liabilities stood at $73.3 billion in 2021, then dropped by 10.38% to $65.7 billion in 2022, then fell by 0.04% to $65.7 billion in 2023, then increased by 16.05% to $76.2 billion in 2024, then fell by 6.14% to $71.5 billion in 2025.
  • Its Total Liabilities stands at $71.5 billion for Q4 2025, versus $78.3 billion for Q3 2025 and $77.2 billion for Q2 2025.